- Report
- September 2024
- 117 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- July 2024
- 221 Pages
Global
From €4444EUR$4,950USD£3,785GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2559EUR$2,850USD£2,179GBP
- Report
- December 2024
- 120 Pages
United States
From €5342EUR$5,950USD£4,549GBP
- Report
- May 2025
- 200 Pages
North America
From €2236EUR$2,490USD£1,904GBP
- Report
- May 2025
- 200 Pages
Europe
From €2236EUR$2,490USD£1,904GBP
- Report
- April 2025
- 85 Pages
United States
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- April 2025
- 127 Pages
Europe
From €3053EUR$3,400USD£2,600GBP
€3591EUR$4,000USD£3,058GBP
- Report
- February 2025
- 88 Pages
United States
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- September 2024
- 150 Pages
Latin America
From €3474EUR$3,869USD£2,958GBP
- Report
- September 2024
- 150 Pages
Europe
From €3474EUR$3,869USD£2,958GBP
- Report
- September 2024
- 150 Pages
Asia Pacific
From €3474EUR$3,869USD£2,958GBP
- Report
- September 2024
- 150 Pages
Africa, Middle East
From €3474EUR$3,869USD£2,958GBP
- Report
- September 2024
- 150 Pages
North America
From €3474EUR$3,869USD£2,958GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3474EUR$3,869USD£2,958GBP
- Report
- June 2025
Global
From €300EUR$358USD£264GBP
- Report
- March 2022
- 405 Pages
Global
From €4309EUR$4,799USD£3,669GBP
- Report
- January 2024
- 307 Pages
Global
From €5287EUR$6,094USD£4,350GBP
- Report
- January 2024
- 370 Pages
Global
From €6662EUR$7,679USD£5,481GBP
- Report
- March 2022
- 312 Pages
Global
From €6285EUR$7,000USD£5,352GBP
The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations.
The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more
